ABOUT US

Nikos Anastasiades has almost 20 years of experience in regulatory compliance function units within the financial markets. He has held previous roles at Lamda Development SA, Société Générale Bank & Trust as well as Argus Stockbrokers Ltd. Nikos holds a BSc in
Economics, a BSc in Business Economics and an MA in International Business, as well as AML Certificate, an Advanced Certificate and a Certificate A1 of the Central Bank of Greece and HCMC, and an Equities Trader Certificate (ATHEX).

Anatoly Fedorov is a Portfolio Manager and the Head of Equities of Signet Group. Anatoly manages Signet’s global leaders portfolio and has experience working with Long-short Equity and Merger Arbitrage strategies. Prior to joining the Investment Manager in February 2018, he worked as a Vice President at J.P. Morgan in EMEA Diversified Industrials Practice. Here he conducted financial and valuation analysis, execution, project management and due diligence on large scale M&A transactions (for example from 2016: Philips Lighting IPO and SGD Pharma sell-side). Prior to his employment at J.P. Morgan, Anatoly was an equity research analyst at Genesis Investment Management. During his time there, he executed financial analysis, valuation and communication with corporate management for emerging markets.

Natalia joined Signet in September 2020 to advise on private market investments with a focus on healthcare. She also acts as an Advisor to select early-stage biomedical and green finance start-ups. Prior to Signet Natalia focused on building an investment platform for pre-seed and seed stage biotechnology ventures working with life sciences entrepreneurs, academia and biotech investors across Europe. Natalia spent years in investment banking in London, specifically focused on Emerging Markets products across global markets divisions and covering institutional investors. She was a Director at UBS Investment Bank, Mizuho International, Senior Associate at VTB Capital and Analyst at Citi. Natalia holds a BSc in Biochemistry from Imperial College London and MSc Management with a focus on pharmaceutical industry from London School of Economics. She uses her scientific background in life sciences to invest in the most advanced and innovative technologies within biotechnology spectrum. Given her previous experience from the investment banking industry Natalia collaborates closely with the Wealth Management division at Signet focussing on alternative investments advisory mandates and a natural interaction with our clients.
Natalia is fluent in English, Italian, French and speaks conversational German.

Robert Marquardt was the Founder of the Signet Group of Companies in the early 1990s and is today Chairman of Signet Wealth Management. Robert, as hedge fund CIO, has managed and advised on investment strategy and hedge fund / alternative investment selection globally since 1994. Through Signet’s offices in Switzerland, London and Hong Kong the group managed and advised on hedge fund selection with an asset level in excess of $3.5 billion at the peak. Prior to founding Signet, Robert was the Managing Director of Chase Private Banking in Luxembourg and a Credit Officer of Chase Manhattan Bank in the Middle East during a 12-year career at the Chase. Robert has deep knowledge of the opportunities and risks in different global economic and market environments across fixed income, equity, commodity and currency strategies through different economic cycles and holding structures.

Daria holds Honours Degrees in Economics and Sociology as well as an M.A. Degree in the Psychology of Personnel Management from the State Education Institution of Higher Professional Education. Today, she heads up Signet’s investor relations and client services, supporting our customers across our full product range.